Similar articles

• Prevention of iron loading in transfusion-dependent thalassaemia.

  Pippard MJ, Letsky EA, Callender ST, Weatherall DJ. Pippard MJ, et al. Lancet. 1978 Jun 3;1(8075):1178-81. doi: 10.1016/s0140-6736(78)90968-6. Lancet. 1978. PMID: 77945
• [Evaluation of iron balance in homozygous beta-thalassemia subjects treated with desferrioxamine administered subcutaneously].

  Ferrara M, Galdo Capotorti M, Ponte G, Esposito L. Ferrara M, et al. Pediatria (Napoli). 1983 Oct-Dec;91(4):371-7. Pediatria (Napoli). 1983. PMID: 6545400 Italian. No abstract available.
• Oral desferrioxamine in young patients with thalassaemia.

  Kattamis C, Fitsialos J, Sinopoulou C. Kattamis C, et al. Lancet. 1981 Jan 3;1(8210):51. doi: 10.1016/s0140-6736(81)90165-3. Lancet. 1981. PMID: 6109092 Clinical Trial. No abstract available.
• Current therapy of Cooley's anemia. A decade of experience with subcutaneous desferrioxamine.

  Giardina PJ, Grady RW, Ehlers KH, Burstein S, Graziano JH, Markenson AL, Hilgartner MW. Giardina PJ, et al. Ann N Y Acad Sci. 1990;612:275-85. doi: 10.1111/j.1749-6632.1990.tb24315.x. Ann N Y Acad Sci. 1990. PMID: 2291555 Review. No abstract available.
• Beta-thalassaemia--the Johannesburg experience.

  Poole JE, Cohn RJ, Roode H, Spector I. Poole JE, et al. S Afr Med J. 1989 Apr 15;75(8):367-70. S Afr Med J. 1989. PMID: 2652340 Review.